Compare QNRX & MMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QNRX | MMA |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6M | 11.8M |
| IPO Year | 2023 | 2023 |
| Metric | QNRX | MMA |
|---|---|---|
| Price | $4.20 | $0.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.2K | ★ 1.4M |
| Earning Date | 05-07-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.10 | $0.35 |
| 52 Week High | $41.80 | $2.00 |
| Indicator | QNRX | MMA |
|---|---|---|
| Relative Strength Index (RSI) | 33.91 | 41.32 |
| Support Level | N/A | $0.38 |
| Resistance Level | $6.84 | $0.53 |
| Average True Range (ATR) | 0.49 | 0.11 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 8.17 | 11.88 |
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
MMA Inc develops technology solutions for the martial arts and combat sports sector. Its platform is designed to support gyms and related businesses by improving areas such as sales channels, customer onboarding, and member engagement. The platform also connects participants, gyms, and communities within the sector, enabling digital management and interaction.